Calcineurin Inhibitor Avoidance With Thymoglobulin and Sirolimus in Kidney Transplantation
Status:
Completed
Trial end date:
2005-03-01
Target enrollment:
Participant gender:
Summary
A prospective, single center, open-label, randomized trial of Thymoglobulin induction and
sirolimus, prednisone, and mycophenolate mofetil versus Thymoglobulin induction and
tacrolimus, prednisone, and mycophenolate mofetil in non-HLA identical living or deceased
donor kidney transplant recipients.
Phase:
Phase 4
Details
Lead Sponsor:
Vanderbilt University Vanderbilt University Medical Center